Oncopharmpod
Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:10
- Mas informaciones
Informações:
Sinopsis
Results from VESPER are now published, so we revisit neoadjuvant ddMVAC and its place as SOC in bladder cancer. Nivolumab nets a new approval with chemo for neoadjuvant treatment of NSCLC. A new CAR-T product is approved for multiple myeloma.
